search
pharmaceutical companies
Trends
- 1Kobayashi Pharmaceutical weighs buyout offer above ¥500 billion●Kobayashi Pharmaceutical, the firm that was at the center of a supplement contamination scandal involving suspected deat
Kobayashi Pharmaceutical, the Japanese maker at the center of a supplement contamination scandal linked to suspected deaths, is reportedly considering a buyout offer worth more than ¥500 billion. The move would mark a major turning point for the company, which has faced reputational and financial fallout since the scandal, and is drawing attention to the future ownership of the troubled firm.
- 2European Capital Backs Colombian Biotech Firm for 250 Million Vaccines●Europe Injects Capital into Colombian Biotech Firm to Produce 250 Million Vaccines
European investors are injecting capital into a Colombian biotechnology company with plans to produce 250 million vaccines. The deal positions Colombia as a growing player in global vaccine manufacturing and reflects Europe's interest in diversifying pharmaceutical production capacity beyond its borders, though details on the funding amount and timeline remain limited.
- 3
Authorities in Kabul have carried out inspections of 75 medicine importers, according to Pajhwok Afghan News. The checks target companies bringing pharmaceutical products into Afghanistan, a sector long plagued by concerns over counterfeit and substandard drugs. The report has drawn attention regionally as Afghans follow efforts to improve oversight of the medicine supply chain.